Biopharmaceutical Cell Culture Market worth $24.47 billion by 2031
The report "Biopharmaceutical Cell Culture Market by Product [Consumables (Media, Sera, Reagents; Accessories), Equipment (Bioreactors, Centrifuges, Filters, Incubators, Freezers)], Type (mAbs, Vaccines, Other), End User (Biopharma, CMOs) - Global Forecast to 2031", is expected to reach USD 24.47 billion by 2031 from USD 12.81 billion in 2026, at a CAGR of 13.8% during the forecast period.
Browse 200 market data Tables and 40 Figures spread through 300 Pages and in-depth TOC on "Biopharmaceutical Cell Culture Market by Product [Consumables (Media, Sera, Reagents; Accessories), Equipment (Bioreactors, Centrifuges, Filters, Incubators, Freezers)], Type (mAbs, Vaccines, Other), End User (Biopharma, CMOs) - Global Forecast to 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/biopharmaceutical-cell-culture-market-83042424.html
Key drivers of growth in the biopharmaceutical cell culture market include the expansion of major pharmaceutical and biotechnology companies, increasing demand for monoclonal antibodies, and growing regulatory approvals for cell culture-based vaccines. The rising adoption of single-use technologies is another growth factor. The growing incidence of infectious diseases has boosted the demand for cell culture products across biopharmaceutical production applications. Access to advanced technologies and solutions can support biopharmaceutical development efforts. For example, regions with better infrastructure for implementing cell culture systems, deploying single-use technologies, and using advanced bioreactors can enhance production capabilities.
The consumables segment accounted for a significant share of the biopharmaceutical cell culture market in 2025.
Consumables, including media, sera, and reagents, among others, are specialized products that support cell culture operations in biopharmaceutical production. Their primary purpose is to maintain cell viability, support cell growth, and ensure optimal culture conditions. These consumables are designed to provide essential nutrients, growth factors, and environmental conditions required for successful cell culture processes. The consumables segment remained dominant in North America, primarily driven by the US in 2025. Consumables are used across biopharmaceutical production facilities and contract manufacturing organizations. Owing to these features and recurring demand patterns, consumables are expected to contribute a major share of the market.
The monoclonal antibody production segment accounted for the largest share of the biopharmaceutical cell culture market in 2025.
Monoclonal antibodies are expected to account for the largest share of the global biopharmaceutical production cell culture market, by type, in 2025. The dominance of this segment is driven by the growing number of approved monoclonal antibody therapies and their extensive use in treating cancer, autoimmune disorders, and other chronic diseases. The continued expansion of biologics manufacturing capacity and increasing development of antibody-based therapies are driving demand for advanced cell culture media, bioreactors, and upstream processing systems.
The Asia Pacific is expected to register a significant CAGR during the forecast period.
Growing biopharmaceutical production and therapeutic development in the Asia Pacific are expected to drive the biopharmaceutical cell culture market. Countries in the region, such as China, Japan, and India, are focusing on developing and adopting cell culture technologies and solutions. The Asia Pacific region is expected to register the highest CAGR of 14.8% during the forecast period. The rising need for biopharmaceutical expansion creates opportunities for companies to expand their market presence and strengthen their technology offerings to meet rising demand during the forecast period.
The report profiles key players, including Thermo Fisher Scientific (US), Danaher (US), Sartorius AG (Germany), Merck KGaA (Germany), Corning Incorporated (US), FUJIFILM Holdings Corporation (Japan), and Eppendorf SE (Germany).
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Biopharmaceutical Cell Culture Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
